nach oben

Current Colorectal Cancer Reports

Erschienen in:

08.03.2016 | Colorectal Cancer Hepatic Metastases (MA Choti, Section Editor)

Minimally Invasive Liver Surgery for Hepatic Colorectal Metastases

verfasst von: Ibrahim Nassour, Patricio M. Polanco

Erschienen in: Current Colorectal Cancer Reports | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Minimally invasive surgery has been cautiously introduced in surgical oncology over the last two decades due to a concern of compromised oncological outcomes. Recently, it has been adopted in liver surgery for colorectal metastases. Colorectal cancer is a major cause of cancer-related death in the USA. In addition, liver metastasis is the most common site of distant disease and its resection improves survival. While open resection was the standard of care, laparoscopic liver surgery has become the standard of care for minor liver resections. Laparoscopic liver surgery provides equivalent oncological outcomes with better perioperative results compared to open liver surgery. Robotic liver surgery has been introduced as it is believed to overcome some of the limitations of laparoscopy. Finally, laparoscopic radio-frequency ablation and microwave coagulation can be used as adjuncts in minimally invasive surgery to complement or replace surgical resection when not possible.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. doi:10.3322/caac.21254.CrossRefPubMed

Frankel TL, D’Angelica MI. Hepatic resection for colorectal metastases. J Surg Oncol. 2013;109(1):2–7. doi:10.1002/jso.23371.CrossRefPubMed

Siegel RL, Ward EM, Jemal A. Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev. 2012;21(3):411–6. doi:10.1158/1055-9965.EPI-11-1020.CrossRefPubMed

Van Cutsem E, Nordlinger B, Adam R, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer. 2006;42(14):2212–21. doi:10.1016/j.ejca.2006.04.012.CrossRefPubMed

[No author] Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project. J Clin Oncol. 1992;10(6):896–903.

Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med. 2000;343(13):905–14. doi:10.1056/NEJM200009283431302.CrossRefPubMed

Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet. 2000;355(9209):1041–7.CrossRefPubMed

Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004;22(1):23–30. doi:10.1200/JCO.2004.09.046.CrossRefPubMed

Cunningham D, Pyrhönen S, James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet. 1998;352(9138):1413–8. doi:10.1016/S0140-6736(98)02309-5.CrossRefPubMed

10.

Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350(23):2335–42. doi:10.1056/NEJMoa032691.CrossRefPubMed

11.

Nathan H, de Jong MC, Pulitano C, et al. Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients. J Am Coll Surg. 2010;210(5):755–66. doi:10.1016/j.jamcollsurg.2009.12.041.CrossRefPubMed

12.

Hamady ZZR, Lodge JPA, Welsh FK, et al. One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach. Ann Surg. 2014;259(3):543–8. doi:10.1097/SLA.0b013e3182902b6e.CrossRefPubMed

13.

Mavros MN, de Jong M, Dogeas E, Hyder O, Pawlik TM. Impact of complications on long-term survival after resection of colorectal liver metastases. Br J Surg. 2013;100(5):711–8. doi:10.1002/bjs.9060.CrossRefPubMed

14.

Andreou A, Aloia TA, Brouquet A, et al. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg. 2013;257(6):1079–88. doi:10.1097/SLA.0b013e318283a4d1.CrossRefPubMedPubMedCentral

15.

Beppu T, Sakamoto Y, Hasegawa K, et al. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a project study for hepatic surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2012;19(1):72–84. doi:10.1007/s00534-011-0460-z.CrossRefPubMed

16.••

Schiffman SC, Kim KH, Tsung A, Marsh JW, Geller DA. Laparoscopic versus open liver resection for metastatic colorectal cancer: a metaanalysis of 610 patients. Surgery. 2015;157(2):211–22. doi:10.1016/j.surg.2014.08.036. This meta-analysis shows that LLR has better perioperative outcomes without compromising oncological outcomes compared to OLR. CrossRefPubMed

17.

Hasegawa Y, Nitta H, Sasaki A, et al. Long-term outcomes of laparoscopic versus open liver resection for liver metastases from colorectal cancer: a comparative analysis of 168 consecutive cases at a single center. Surgery. 2015;157(6):1065–72. doi:10.1016/j.surg.2015.01.017.CrossRefPubMed

18.

Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13(1):51–64. doi:10.1634/theoncologist.2007-0142.CrossRefPubMed

19.

Pawlik TM, Choti MA. Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg. 2007;11(8):1057–77. doi:10.1007/s11605-006-0061-3.CrossRefPubMed

20.

Gagner M, Rheault M, Dubuc J. Laparoscopic partial hepatectomy for liver tumor. Surg Endosc. 1992;6:97–8.

21.

Azagra JS, Goergen M, Gilbart E, Jacobs D. Laparoscopic anatomical (hepatic) left lateral segmentectomy-technical aspects. Surg Endosc. 1996;10(7):758–61.CrossRefPubMed

22.

Talamini MA. Advanced therapy in minimally invasive surgery. USA: PMPH; 2006.

23.

Wayand W, Woisetschläger R. Laparoscopic resection of liver metastasis. Chirurg. 1993;64(3):195–7.PubMed

24.

Wakabayashi G, Cherqui D, Geller DA, et al. Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg. 2015;261:619–29. doi:10.1097/SLA.0000000000001180.PubMed

25.

Buell JF, Cherqui D, Geller DA, et al. The international position on laparoscopic liver surgery: the Louisville Statement, 2008. Ann Surg. 2009;250:825–30.CrossRefPubMed

26.

Sahay SJ, Fazio F, Cetta F, Chouial H, Lykoudis PM, Fusai G. Laparoscopic left lateral hepatectomy for colorectal metastasis is the standard of care. J BUON. 2015;20(4):1048–53.PubMed

27.

Cherqui D, Husson E, Hammoud R, et al. Laparoscopic liver resections: a feasibility study in 30 patients. Ann Surg. 2000;232(6):753–62.

28.

Geller DA, Tsung A. Long-term outcomes and safety of laparoscopic liver resection surgery for hepatocellular carcinoma and metastatic colorectal cancer. J Hepatobiliary Pancreat Sci. 2015;22(10):728–30. doi:10.1002/jhbp.278.CrossRefPubMed

29.

Tamandl D, Herberger B, Gruenberger B, et al. Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases. Surgery. 2008;143(5):648–57. doi:10.1016/j.surg.2007.11.020.CrossRefPubMed

30.

van Vledder MG, Pawlik TM, Munireddy S, Hamper U, de Jong MC, Choti MA. Factors determining the sensitivity of intraoperative ultrasonography in detecting colorectal liver metastases in the modern era. Ann Surg Oncol. 2010;17(10):2756–63. doi:10.1245/s10434-010-1108-y.CrossRefPubMed

31.

Conlon R, Jacobs M, Dasgupta D, Lodge JPA. The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound. 2003;16(3):211–6.CrossRefPubMed

32.

Viganò L, Ferrero A, Amisano M, Russolillo N, Capussotti L. Comparison of laparoscopic and open intraoperative ultrasonography for staging liver tumours. Br J Surg. 2013;100(4):535–42. doi:10.1002/bjs.9025.CrossRefPubMed

33.

The ORANGE II PLUS - Trial: open versus laparoscopic hemihepatectomy. 2015. https://clinicaltrials.gov/ct2/show/NCT01441856. Accessed 15 Dec 2015.

34.

Oslo Randomized Laparoscopic Versus Open Liver Resection for Colorectal Metastases Study (Oslo-CoMet). 2015. https://clinicaltrials.gov/ct2/show/NCT01516710?term=oslo+comet+study&rank=1. Accessed 15 Dec 2015.

35.

Parks KR, Kuo Y-H, Davis JM, O’Brien B, Hagopian EJ. Laparoscopic versus open liver resection: a meta-analysis of long-term outcome. HPB. 2013;16(2):109–18. doi:10.1111/hpb.12117.CrossRefPubMedPubMedCentral

36.

Luo L-X, Yu Z-Y, Bai Y-N. Laparoscopic hepatectomy for liver metastases from colorectal cancer: a meta-analysis. J Laparoendosc Adv Surg Tech A. 2014;24(4):213–22. doi:10.1089/lap.2013.0399.CrossRefPubMed

37.

Wei M, He Y, Wang J, Chen N, Zhou Z, Wang Z. Laparoscopic versus open hepatectomy with or without synchronous colectomy for colorectal liver metastasis: a meta-analysis. PLoS One. 2014;9(1):e87461–9. doi:10.1371/journal.pone.0087461.CrossRefPubMedPubMedCentral

38.

Zhou Y, Xiao Y, Wu L, Li B, Li H. Laparoscopic liver resection as a safe and efficacious alternative to open resection for colorectal liver metastasis: a meta-analysis. BMC Surg. 2013;13:44. doi:10.1186/1471-2482-13-44

39.

Montalti R, Berardi G, Laurent S, et al. Laparoscopic liver resection compared to open approach in patients with colorectal liver metastases improves further resectability: oncological outcomes of a case-control matched-pairs analysis. Eur J Surg Oncol. 2014;40(5):536–44. doi:10.1016/j.ejso.2014.01.005.CrossRefPubMed

40.

Tohme S, Goswami J, Han K, et al. Minimally invasive resection of colorectal cancer liver metastases leads to an earlier initiation of chemotherapy compared to open surgery. J Gastrointest Surg. 2015. doi:10.1007/s11605-015-2962-5.PubMed

41.

Cannon RM, Scoggins CR, Callender GG, Quillo A, McMasters KM, Martin RCG. Financial comparison of laparoscopic versus open hepatic resection using deviation-based cost modeling. Ann Surg Oncol. 2013;20(9):2887–92. doi:10.1245/s10434-013-2993-7.CrossRefPubMed

42.

Vanounou T, Steel JL, Nguyen KT, et al. Comparing the clinical and economic impact of laparoscopic versus open liver resection. Ann Surg Oncol. 2009;17(4):998–1009. doi:10.1245/s10434-009-0839-0.CrossRefPubMedPubMedCentral

43.

History of surgical robotics. 2015. http://www.avrasurgicalrobotics.com/historyofsurgicalrobotics.html. Accessed 15 Dec 2015.

44.

Giulianotti PC. Robotics in general surgery. Arch Surg. 2003;138(7):777. doi:10.1001/archsurg.138.7.777.CrossRefPubMed

45.

Casciola L, Patriti A, Ceccarelli G, Bartoli A, Ceribelli C, Spaziani A. Robot-assisted parenchymal-sparing liver surgery including lesions located in the posterosuperior segments. Surg Endosc. 2011;25(12):3815–24. doi:10.1007/s00464-011-1796-9.CrossRefPubMed

46.

Kingham TP, Scherer MA, Neese BW, Clements LW, Stefansic JD, Jarnagin WR. Image-guided liver surgery: intraoperative projection of computed tomography images utilizing tracked ultrasound. HPB. 2012;14(9):594–603. doi:10.1111/j.1477-2574.2012.00487.x.CrossRefPubMedPubMedCentral

47.

Tsung A, Geller DA, Sukato DC, et al. Robotic versus laparoscopic hepatectomy: a matched comparison. Ann Surg. 2014;259(3):549–55. doi:10.1097/SLA.0000000000000250.CrossRefPubMed

48.

Berber E, Akyildiz HY, Aucejo F, Gunasekaran G, Chalikonda S, Fung J. Robotic versus laparoscopic resection of liver tumours. HPB. 2010;12(8):583–6. doi:10.1111/j.1477-2574.2010.00234.x.CrossRefPubMedPubMedCentral

49.

Ji W-B, Wang H-G, Zhao Z-M, Duan W-D, Lu F, Dong J-H. Robotic-assisted laparoscopic anatomic hepatectomy in China: initial experience. Ann Surg. 2011;253(2):342–8. doi:10.1097/SLA.0b013e3181ff4601.CrossRefPubMed

50.

Tranchart H, Ceribelli C, Ferretti S, Dagher I, Patriti A. Traditional versus robot-assisted full laparoscopic liver resection: a matched-pair comparative study. World J Surg. 2014;38(11):2904–9. doi:10.1007/s00268-014-2679-8.CrossRefPubMed

51.

Wu Y-M, Hu R-H, Lai H-S, Lee P-H. Robotic-assisted minimally invasive liver resection. Asian J Surg. 2014;37(2):53–7. doi:10.1016/j.asjsur.2014.01.015.CrossRefPubMed

52.

Spampinato MG, Coratti A, Bianco L, et al. Perioperative outcomes of laparoscopic and robot-assisted major hepatectomies: an Italian multi-institutional comparative study. Surg Endosc. 2014;28(10):2973–9. doi:10.1007/s00464-014-3560-4.CrossRefPubMed

53.

Choi GH, Choi SH, Kim SH, et al. Robotic liver resection: technique and results of 30 consecutive procedures. Surg Endosc. 2012;26(8):2247–58. doi:10.1007/s00464-012-2168-9.CrossRefPubMed

54.

Chan OCY, Tang C-N, Lai ECH, Yang GPC, Li MKW. Robotic hepatobiliary and pancreatic surgery: a cohort study. J Hepatobiliary Pancreat Sci. 2011;18(4):471–80. doi:10.1007/s00534-011-0389-2.CrossRefPubMed

55.

Lai ECH, Tang C-N, Li MKW. Robot-assisted laparoscopic hemi-hepatectomy: technique and surgical outcomes. Int J Surg. 2012;10(1):11–5. doi:10.1016/j.ijsu.2011.10.005.CrossRefPubMed

56.

Patriti A, Ceccarelli G, Bartoli A, Spaziani A, Lapalorcia LM, Casciola L. Laparoscopic and robot-assisted one-stage resection of colorectal cancer with synchronous liver metastases: a pilot study. J Hepatobiliary Pancreat Surg. 2009;16(4):450–7. doi:10.1007/s00534-009-0073-y.CrossRefPubMed

57.

Wakabayashi G, Sasaki A, Nishizuka S, Furukawa T, Kitajima M. Our initial experience with robotic hepato-biliary-pancreatic surgery. J Hepatobiliary Pancreat Sci. 2011;18(4):481–7. doi:10.1007/s00534-011-0388-3.CrossRefPubMed

58.

Croner RS, Perrakis A, Brunner M, Matzel KE, Hohenberger W. Pioneering robotic liver surgery in Germany: first experiences with liver malignancies. Front Surg. 2015;2:18. doi:10.3389/fsurg.2015.00018.CrossRefPubMedPubMedCentral

59.

Felli E, Santoro R, Colasanti M, Vennarecci G, Lepiane P, Ettorre GM. Robotic liver surgery: preliminary experience in a tertiary hepato-biliary unit. Updates Surg. 2015;67(1):27–32. doi:10.1007/s13304-015-0285-4.CrossRefPubMed

60.

Montalti R, Patriti A, Troisi RI. Robotic versus laparoscopic hepatectomy. Ann Surg. 2015;262(2):e70–2. doi:10.1097/SLA.0000000000000701.CrossRefPubMed

61.

Giulianotti PC, Coratti A, Sbrana F, et al. Robotic liver surgery: results for 70 resections. Surgery. 2011;149(1):29–39. doi:10.1016/j.surg.2010.04.002.CrossRefPubMed

62.

Yu Y-D, Kim K-H, Jung D-H, et al. Robotic versus laparoscopic liver resection: a comparative study from a single center. Langenbecks Arch Surg. 2014;399(8):1039–45. doi:10.1007/s00423-014-1238-y.CrossRefPubMed

63.

Packiam V, Bartlett DL, Tohme S, et al. Minimally invasive liver resection: robotic versus laparoscopic left lateral sectionectomy. J Gastrointest Surg. 2012;16(12):2233–8. doi:10.1007/s11605-012-2040-1.CrossRefPubMedPubMedCentral

64.

Montalti R. Outcomes of robotic vs laparoscopic hepatectomy: a systematic review and meta-analysis. WJG. 2015;21(27):8441–12. doi:10.3748/wjg.v21.i27.8441.CrossRefPubMedPubMedCentral

65.••

Qiu J, Chen S, Chengyou D. A systematic review of robotic-assisted liver resection and meta-analysis of robotic versus laparoscopic hepatectomy for hepatic neoplasms. Surg Endosc. 2015. doi:10.1007/s00464-015-4306-7. This is the largest meta-analysis showing that operative time was longer in RLR, but there was no difference in conversion rate, negative margins, morbidity, or mortality compared to LLR.

66.

Ocuin LM, Tsung A. Robotic liver resection for malignancy: current status, oncologic outcomes, comparison to laparoscopy, and future applications. J Surg Oncol. 2015;112(3):295–301. doi:10.1002/jso.23901.CrossRefPubMed

67.

Abdalla EK, Vauthey J-N, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239(6):818–27. doi:10.1097/01.sla.0000128305.90650.71.CrossRefPubMedPubMedCentral

68.

Pwint TP, Midgley R, Kerr DJ. Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liver. Semin Oncol. 2010;37(2):149–59. doi:10.1053/j.seminoncol.2010.03.005.CrossRefPubMed

69.

Rocha FG, D’Angelica M. Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation. J Surg Oncol. 2010;102(8):968–74. doi:10.1002/jso.21720.CrossRefPubMed

70.

Morris-Stiff G, Marangoni G, Hakeem A, et al. Redefining major hepatic resection for colorectal liver metastases: analysis of 1111 liver resections. Int J Surg. 2015. doi:10.1016/j.ijsu.2015.07.711.PubMed

71.

McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Investig Radiol. 1990;25(3):267.CrossRef

72.

Decadt B, Siriwardena AK. Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol. 2004;5(9):550–60. doi:10.1016/S1470-2045(04)01567-0.CrossRefPubMed

73.

Siperstein AE, Berber E, Ballem N, Parikh RT. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg. 2007;246(4):559–65. doi:10.1097/SLA.0b013e318155a7b6. Discussion 565–7.CrossRefPubMed

74.

Ruers T, Punt C, Van Coevorden F, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23(10):2619–26. doi:10.1093/annonc/mds053.CrossRefPubMedPubMedCentral

75.

Aliyev S, Agcaoglu O, Aksoy E, et al. Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastasis. Surgery. 2013;154(3):556–62. doi:10.1016/j.surg.2013.03.009.CrossRefPubMed

76.•

Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158–71. doi:10.1097/01.sla.0000171032.99149.fe. This meta-analysis shows that a tumor bigger than 3 cm has a higher recurrence rate if treated by RFA. CrossRefPubMedPubMedCentral

77.

Foroutani A. Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors. Arch Surg. 2000;135(8):933–8. doi:10.1001/archsurg.135.8.933.CrossRefPubMed

78.

Tabuse K. A new operative procedure of hepatic surgery using a microwave tissue coagulator. Nihon Geka Hokan. 1979;48(2):160–72.PubMed

79.

Yokoyama T, Egami K, Miyamoto M, et al. Percutaneous and laparoscopic approaches of radiofrequency ablation treatment for liver cancer. J Hepatobiliary Pancreat Surg. 2003;10(6):425–7. doi:10.1007/s00534-002-0830-7.CrossRefPubMed

80.

Jagad RB, Koshariya M, Kawamoto J, et al. Laparoscopic microwave ablation of liver tumors: our experience. Hepatogastroenterology. 2008;55(81):27–32.PubMed

81.

Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer. 2000;89(2):276–84.CrossRefPubMed

82.

Jiao LR, Habib NA. Experimental study of large-volume microwave ablation in the liver. Br J Surg. 2003;90(1):122. doi:10.1002/bjs.4088.CrossRefPubMed

83.

Seki T, Wakabayashi M, Nakagawa T, et al. Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer: a pilot clinical study. Am J Gastroenterol. 1999;94(2):322–7. doi:10.1111/j.1572-0241.1999.00849.x.CrossRefPubMed

84.

Correa-Gallego C, Fong Y, Gonen M, et al. A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases. Ann Surg Oncol. 2014;21(13):4278–83. doi:10.1245/s10434-014-3817-0.CrossRefPubMedPubMedCentral

85.

Leung U, Kuk D, D’Angelica MI, et al. Long-term outcomes following microwave ablation for liver malignancies. Br J Surg. 2015;102(1):85–91. doi:10.1002/bjs.9649.CrossRefPubMedPubMedCentral

86.

Groeschl RT, Pilgrim CHC, Hanna EM, et al. Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg. 2014;259(6):1195–200. doi:10.1097/SLA.0000000000000234.CrossRefPubMed

87.

Yu NC, Raman SS, Kim YJ, Lassman C, Chang X, Lu DSK. Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model. J Vasc Interv Radiol. 2008;19(7):1087–92. doi:10.1016/j.jvir.2008.03.023.CrossRefPubMed

88.

Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee FT. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology. 2005;236(1):132–9. doi:10.1148/radiol.2361031249.CrossRefPubMed

89.

Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005;25(1):S69–83. doi:10.1148/rg.25si055501.CrossRefPubMed

90.•

Stättner S, Primavesi F, Yip VS, et al. Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience. Surg Today. 2014;45(4):407–15. doi:10.1007/s00595-014-0879-3. This study shows the feasibility and safety of laparoscopic MWC. CrossRefPubMed

Titel: Minimally Invasive Liver Surgery for Hepatic Colorectal Metastases
verfasst von: Ibrahim Nassour
Patricio M. Polanco
Publikationsdatum: 08.03.2016
Verlag: Springer US
Erschienen in: Current Colorectal Cancer Reports / Ausgabe 2/2016
Print ISSN: 1556-3790
Elektronische ISSN: 1556-3804
DOI: https://doi.org/10.1007/s11888-016-0316-7

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Minimally Invasive Liver Surgery for Hepatic Colorectal Metastases

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2016

Management of Early (T1 or T2) Rectal Cancer

In Deciphering the Future of Adjuvant Treatment in Colon Cancer, the Journey Matters More than the Achievements

Liver-Directed Therapy in Metastatic Colorectal Cancer

What is the Best Colonoscopy Surveillance for Lynch Syndrome Patients?

The Importance of Increased Serrated Polyp Detection Rate

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie